Prevalence and predictors of elevated aspartate aminotransferase-to- platelet ratio index in latin American perinatally HIV-infected children

Pediatric Infectious Disease Journal

Volumn 33, Issue 2, 2014, Pages 177-182

  Siberry, George K ^a   Cohen, Rachel A ^b   Harris, D Robert ^b   Cruz, Maria Leticia Santos ^c   Oliveira, Ricardo ^d   Peixoto, Mario F ^e   Cervi, Maria Celia ^f   Hazra, Rohan ^a   Pinto, Jorge A ^g  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b Hospital Federal dos Servidores do Estado ^*

^c Division of Pediatric Surgery and Pediatric Urology Department of Surgery   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e Hospital Fêmina   (Brazil)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

aspartate aminotransferase to platelet ratio index; HIV 1; Latin America; perinatal HIV infection

Indexed keywords

ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR;

AGE DISTRIBUTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; CD4 LYMPHOCYTE COUNT; CHILD; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NATIONAL HEALTH ORGANIZATION; OBSERVATIONAL STUDY; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA; VIRUS LOAD;

ASPARTATE AMINOTRANSFERASES; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LATIN AMERICA; LIVER CIRRHOSIS; MALE; PLATELET COUNT; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 84893012045     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182a01dfb     Document Type: Article

References (29)

1. Sauvageot D, Schaefer M, Olson D, et al. Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children 5 years of age. Pediatrics. 2010;125e1039-e1047
2. Brinkhof MW, Boulle A, Weigel R, et al.; International Epidemiological Databases to Evaluate AIDS (IeDEA). Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa comparison with HIVunrelated mortality. PLoS Med. 2009;6e1000066
3. Moh R, Danel C, Messou E, et al. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIVinfected adults in West Africa. AIDS. 2007;212483-2491
4. TDCoAEoA-HIVdS Group. Factors associated with specific causes of death amongst HIV-positive individuals in the DAD study. AIDS. 2010;241537-1548
5. Price JC, Thio CL. Liver disease in the HIV-infected individual. Clin Gastroenterol Hepatol. 2010;81002-1012
6. Mata-Marin JA, Gaytan-Martinez J, Grados-Chavarria BH, et al. Correlation between HIV viral load and aminotransferases as liver damage markers in HIV-infected naive patients a concordance cross-sectional study. Virol J. 2009;6181
7. Telatela SP, Matee MI, Munubhi EK. Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania. BMC Public Health. 2007;7338
8. Zhou S, Zhao Y, He Y, et al. Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009. J Acquir Immune Defic Syndr. 2010;54191-196
9. Aurpibul L, Lumbiganon P, Kolasaraksa P, et al. HIV and hepatitis B coinfection among perinatally HIV-infected Thai adolescents. Pediatr Infect Dis J. 2012;31943-947
10. Price JC, Seaberg EC, Badri S, et al. HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. J Infect Dis. 2012;2051005-1013
11. DallaPiazza M, Amorosa VK, Localio R, et al. Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients. BMC Infect Dis. 2010;10116
12. Al-Mohri H, Cooper C, Murphy T, et al. Validation of a simple model for predicting liver fibrosis in HIVhepatitis C virus-coinfected patients. HIV Med. 2005;6375-378
13. Kelleher TB, Mehta SH, Bhaskar R, et al. Prediction of hepatic fibrosis in HIVHCV co-infected patients using serum fibrosis markers the SHASTA index. J Hepatol. 2005;4378-84
14. Nunes D, Fleming C, Offner G, et al. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr. 2005;40538-544
15. Moodie EE, Pant Pai N, Klein MB. Is antiretroviral therapy causing longterm liver damage A comparative analysis of HIV-mono-infected and HIV hepatitis C co-infected cohorts. PLoS One. 2009;4e4517
16. Sterling RK, Lissen E, Clumeck N, et al.; APRICOT Clinical Investigators. Development of a simple noninvasive index to predict significant fibrosis in patients with HIVHCV coinfection. Hepatology. 2006;431317-1325
17. Bambha K, Pierce C, Cox C, et al. Assessing mortality in women with hepatitis C virus and human immunodeficiency virus using indirect markers of fibrosis. AIDS. 2012;26599-607
18. Mendeni M, Focà E, Gotti D, et al. Evaluation of liver fibrosis concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection. Clin Infect Dis. 2011;521164-1173
19. McGoogan KE, Smith PB, Choi SS, et al. Performance of the ASTto-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis. J Pediatr Gastroenterol Nutr. 2010;50344-346
20. de Lédinghen V, Le Bail B, Rebouissoux L, et al. Liver stiffness measurement in children using FibroScan feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr. 2007;45443-450
21. Kim SY, Seok JY, Han SJ, et al. Assessment of liver fibrosis and cirrhosis by aspartate aminotransferase-to-platelet ratio index in children with biliary atresia. J Pediatr Gastroenterol Nutr. 2010;51198-202
22. Mangus RS, O'Connor MG, Tector AJ, et al. Use of the aspartate aminotransferase to platelet ratio index to follow liver fibrosis progression in infants with short gut. J Pediatr Surg. 2010;451266-1273
23. Hazra R, Stoszek SK, Freimanis Hance L, et al.; NISDI Pediatric Study Group 2008. Cohort Profile NICHD International Site Development Initiative (NISDI) a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries. Int J Epidemiol. 2009;381207-1214
24. Pediatric Dosage Handbook. 14th ed. Hudson, OH Lexi-Comp; 2007
25. The Harriet Lane Handbook. In Arcara K, Tschudy M, eds. 19th ed. Philadelphia, PA Elsevier Mosby, Inc; 2011
26. Micromedex Healthcare Series [Internet Database]. Greenwood Village, CO Thomson Reuters (Healthcare) Inc; 2011
27. Kovari H, Ledergerber B, Peter U, et al.; Swiss HIV Cohort Study. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine a nested case-control study. Clin Infect Dis. 2009;49626-635
28. Kochin I, Magid M, Arnon R, et al. Variceal bleeding in an adolescent with HIV diagnosed with hepatoportal sclerosis and nodular regenerative hyperplasia. J Pediatr Gastroenterol Nutr. 2010;50340-343
29. Blackard JT, Welge JA, Taylor LE, et al. HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis. 2011;52674-680 Development Development Development